Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Cypriots safeguard medicines availability

As a small market, the Republic of Cyprus tries to ensure the availability of a wide range of veterinary medicines in the country, says Cyprus' chief veterinary officer and head of animal health and welfare Dr Giorgos Neophytou. He talks to Animal Pharm about the importance of having a variety of veterinary medicines, not only as a means of protecting animal health, but to also help prevent monopolies, where only one medicine is available for a given disease. Dr Neophytou explains how his agency applies various marketing authorization (MA) procedures to encourage veterinary drug manufacturers to launch products on to the Cypriot market.



What to read next




Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts